• Home
  • >
  • Neuland Laboratories Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/neuland-laboratories-ltd.png Logo

Neuland Laboratories Ltd Financial Statement

Neuland Laboratories Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue390.37394.93420.8
Operating Expense278.22272.26280.45
Net Profit67.6180.789.06
Net Profit Margin17.3220.4321.16
Earning Per Share52.762.969.42
EBIDTA109.6124.86139.44
Effective Tax Rate19.5520.6122.4

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Neuland Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual1,191.2951.08936.91
Operating Expenses Annual919.36808.46790.09
Operating Profit Annual281.59144.7162.91
Interest Annual13.0713.517.9
Depreciation51.5247.5638.4
Net Profit Annual163.5263.8280.63
Tax Annual52.2318.3424.7

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Neuland Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning5.092.4411.2
Cash Flow from Operations237.2160.39189.36
Cash Flow from Investing-61.09-95.45-84.47
Cash Flow from Financing-135.837.72-113.66
Cash Flow at the End45.425.092.44

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Neuland Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)23.6415.2116.02
PBIT Margin (%)19.2110.0611.79
PBT Margin (%)17.749.3111.13
Net PROFIT Margin (%)13.696.688.57
Return On Networth / Equity (%)17.847.859.48
Return On Networth /Employed(%)20.589.2311.1
Return On Assets (%)14.656.158.06
Total Debt / Equity(X)0.20.260.3
Asset Turnover Ratio (%)1.070.920.94

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Neuland Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual738.19747.7696.94
Total Current Assets Annual760.89580.79549.59
Non Current Assets Annual818.87802.7775.2
Total Shareholders Funds Annual994.1840.5786.46
Total Assets Annual1,579.761,383.491,324.79

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Neuland Laboratories Ltd Earning Calls
Mar 2024
EPS beaten by 0.55 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Neuland Laboratories Ltd has a market capitalization of 8,058.84 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Neuland Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.07.

In FY 2023, Neuland Laboratories Ltd recorded a total revenue of approximately 1,558.58 Cr marking a significant milestone in the company's financial performance.

Neuland Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.9% and 0.2% annually, respectively..

Neuland Laboratories Ltd's current PE ratio is 26.86.

Neuland Laboratories Ltd's ROCE averaged 19.8% from the FY ending March 2022 to 2024, with a median of 20.4%. It peaked at 30.1% in March 2024, reflecting strong capital efficiency over the period..

Neuland Laboratories Ltd's latest EBIT is Rs. 415.44 Cr, surpassing the average EBIT of Rs. 246.64 Cr over the 5 years..